Bay City Capital Expands Team With the Addition of David Beier, JD
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN FRANCISCO--(BUSINESS WIRE)--Bay City Capital, a leading venture capital firm focused on early-stage to growth equity investments in the life sciences, today announced the addition of David Beier, JD as Managing Director. David served as a senior officer for nearly a decade in each of the two largest biotechnology firms, Genentech and Amgen. Most recently, David served as Senior Vice President of Global Government Affairs at Amgen, responsible for global government affairs, as well as corporate communications, and philanthropy.
Help employers find you! Check out all the jobs and post your resume.
SAN FRANCISCO--(BUSINESS WIRE)--Bay City Capital, a leading venture capital firm focused on early-stage to growth equity investments in the life sciences, today announced the addition of David Beier, JD as Managing Director. David served as a senior officer for nearly a decade in each of the two largest biotechnology firms, Genentech and Amgen. Most recently, David served as Senior Vice President of Global Government Affairs at Amgen, responsible for global government affairs, as well as corporate communications, and philanthropy.
Help employers find you! Check out all the jobs and post your resume.